UnitedHealth Group stock is a top dividend growth stock with solid returns, reliable yield, and long-term growth prospects.

Discover why UnitedHealth stock rebounded after a sharp decline, future growth prospects, and how strategic changes may offer ...

Shares of the healthcare giant are still down more than 30% year to date, after plunging as much as 53% at one point. Should ...

A political battle continues within the U.S. government over renewing expired Affordable Care Act (ACA) subsidies. The ...

UnitedHealth Group has agreed to sell its last South American business Banmedica to Brazilian private equity group Patria ...

Mairs & Power, an investment advisor, released the third-quarter 2025 investor letter for the “Mairs & Power Balanced Fund.” A copy of the letter can be downloaded here. As we move into 2025, the ...

UnitedHealth Group Inc. defeated an insurance reimbursement suit Tuesday after a federal appeals court affirmed the Employee ...

The billionaire saw better places to park his Appaloosa hedge fund's money than in a beleaguered healthcare giant.

UnitedHealth Group, the company that owns healthcare conglomerate UnitedHealth, said on Thursday that it is cooperating with the federal government as it fields criminal and civil requests from ...

Former UnitedHealth Group CEO William McGuire joins mediation team for Fairview and University of Minnesota merger negotiations.

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. UnitedHealth Group profits fell to $3.4 billion in the second quarter as ...

UnitedHealth Group has reached a deal to sell its Latin American business Banmedica for $1 billion, according to media ...